Your browser doesn't support javascript.
loading
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
Pfreundschuh, Michael; Ho, Anthony D; Cavallin-Stahl, Eva; Wolf, Max; Pettengell, Ruth; Vasova, Ingrid; Belch, Andrew; Walewski, Jan; Zinzani, Pier-Luigi; Mingrone, Walter; Kvaloy, Stein; Shpilberg, Ofer; Jaeger, Ulrich; Hansen, Mads; Corrado, Claudia; Scheliga, Adriana; Loeffler, Markus; Kuhnt, Evelyn.
Affiliation
  • Pfreundschuh M; Saarland University Medical School, Homburg, Germany.
Lancet Oncol ; 9(5): 435-44, 2008 May.
Article in En | MEDLINE | ID: mdl-18400558
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Patient Selection Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Patient Selection Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Germany